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Abstract 
 
 
The following literature review will focus on sexual dysfunction in women living with diabetes, drawing on 
international studies in this specialist field. The key aim of this paper is generate a greater understanding 
and recognition of the issues facing these women and to determine a more proactive approach to 
identification, consultation and potential treatment options. The main findings highlight the unique role 
practitioners have with women with diabetes and how to facilitate partnership working. Nurses have the 
most frequent contact with people living with diabetes in any healthcare system. Nurses’ knowledge about 
sexuality in relation to diabetes should improve patient education, recognition and could signal 
undiagnosed or increased risk of sexual dysfunction to enable treatment so care can be optimised 
accordingly (Sivrikaya et al, 2014). 
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Introduction 
Sex is an important part of all adult relationships and increasingly Female Sexual Dysfunction (FSD) has 
become more recognised as an aspect of many women’s experiences, especially those living with diabetes.  
However, the historical paucity of research into FSD, as compared to male, is only becoming addressed 
more frequently in more recent years. A key reason being related to an emphasis on traditional research 
approaches regarding recognition of male sexual dysfunction linking to reproduction purposes whereas 
female sexual functioning not having this requirement (Maiorion et al, 2014). Female sexuality has begun 
to be considered as an important aspect of women’s health with the World Health Organisation (WHO, 
2014) declaring this as a basic human right.  Exploring sexuality and sexual wellbeing with women is part of 
the holistic nature of care and therefore the complexities of sexual identity and sexual dysfunction relating 
to living with diabetes need recognition within practice (Phillips & Khan, 2010). 
Female Sexual Dysfunction 
FSD has several causes including interpersonal, contextual (social), psychological and biological (Berman, 
2005).  Consequently, every factor contributing to normal sexual functioning can be a potential cause of 
dysfunction. The first phase of female sexual response is governed by a combination of neuromuscular and 
vasocongestive events including increased clitoral size (diameter and length), vaginal lubrication and wall 
engorgement (Otunctemur et al, 2014).  Orgasm is the culmination of sexual arousal, although Lloyd (2005) 
reported approximately 90% of women report orgasm from some form of sexual stimulation, most women 
do not and some never experience orgasm solely from sexual intercourse, whereas 100% of men routinely 
experience orgasm solely from sexual intercourse.  
 Maiorino et al (2014) reported that normal sexual response requires the integrity of the sensory and 
automatic nervous systems responding to erotic stimuli. The smooth muscle relaxation of the female 
genital erectile tissue and increase in blood supply are dependent on the healthy action of non-adrenergic 
/ non-cholinergic neurotransmitters. The regulation of blood supply and clitoral erectile function is 
governed by the same vasoactive intestinal polypeptides such as Nitric Oxide and cGMP that govern 
erectile functioning in males. Bargiota et al, (2011) also reported that normal levels of various hormones 
are required for physiologic sexual activity.  Diabetes can potentially disrupt all of these integrated systems 
triggering females to experience sexual dysfunction. The systems involved include hyperglycaemia, 
vascular and neuropathic damage, infections and hormonal disorders. 
In males, orgasms are under ‘strong selective pressure’ as orgasms are coupled with ejaculation thus 
contributing to reproductive success (Wallen & Lloyd, 2010). By contrast, female orgasms in intercourse 
are under little selective pressure as they do not constitute a reproductive necessity. Normal sexual 
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function in females occurs by an interaction between emotional and physical wellbeing, this complex 
interaction maybe modified by disease, anatomic, physiological and/or emotional causes (Vaccaro et al, 
2014).  
Sexual difficulties in females appear currently more readily recognised in society (Maiorino et al, 2014) 
with large epidemiological US studies reporting the prevalence of FSD to be 40-60% (Shifren et al, 2008, 
Dennerstein et al, 2002, Lindau et al, 2007) with highest values reported in postmenopausal females. 
Diabetes 
Diabetes is one of the most common long term diseases in nearly all countries and is increasing to 
epidemic proportions; the International Diabetes Federation (IDF, 2015) reported a world prevalence of 
387 million people diagnosed and living with diabetes which is 8.3% of the world population. Also 
predicted is 46.3% of the world population being undiagnosed currently. The prevalence of diabetes is 
anticipated to reach 592 million by 2025 (IDF, 2015).  A higher prevalence of FSD has been associated with 
diabetes (Maiorino et al, 2014).  
Research into the arterial blood supply supplying the female pelvic anatomy relating to the presence of 
atherosclerosis of the arterial bed can lead to decreased vaginal engorgement and clitoral insufficiency 
syndrome resulting in vasculogenic FSD (Doumas et al, 2005, Gragasin et al, 2004). Additionally the 
prevalence of Metabolic Syndrome increases during the fifth and sixth decades of women’s lives and also 
coincides with the onset of the menopause hence associated with the lower oestrogenic milieu which 
enhances risk factors for metabolic syndrome such as increased insulin resistance, obesity and 
hyperglycaemia (Otunctemur et al, 2014). Hyperglycaemia is the main determinant of preventable vascular 
and neuropathic complications of diabetes and control of risk factors in a person centred partnership is the 
focus of effective diabetes care (Phillips, 2012).  
FSD is associated with both type 1 insulin dependent diabetes (Enzlin et al, 2009) and type 2 diabetes 
(Giugliano et al, 2010). A meta-analysis by Pontiroli et al, (2013) which included 26 studies and 3,168 
women with diabetes compared to 2,832 controls reported that the risk for sexual dysfunction was 2.27 
(95% confidence interval (CI) with 2.49 (CI 1.55 – 3.99) in type 1 and type 2 diabetes respectively. 
Interestingly, Pontiroli et al, (2013) reported increased risk of FSD in premenopausal rather than 
postmenopausal females. 
The presence of prolonged hyperglycaemia reduces the hydration of the vaginal mucus membranes, 
producing reduced lubrication and females experiencing dyspareunia (Ismail et al, 2014, Erten et al, 2013). 
Hyperglycaemia also increases the risk and incidence of genitourinary and fungal infections which can 
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cause vaginal discomfort and dyspareunia (Phillips, 2012).  Vascular and neuropathic complications of 
diabetes can cause decreased nerve stimulation and blood flow, which inhibits sexual response to stimuli, 
thereby impairs reaction of the vaginal tissue to reduced nerve stimulation (Maiorino et al, 2014).  Vascular 
abnormalities including atherosclerotic damage and diabetes-induced endothelial dysfunction are 
postulated to also interfere with clitoral engorgement and vaginal lubrication which lead to decreased 
arousal and dyspareunia during intercourse. Additionally the presence of neuropathy can further 
participate by altering the normal transduction of sexual stimuli and triggered sexual response (Duby et al, 
2004). 
Several endocrine pathways are associated with diabetes; Bhasin et al, (2007) and Feldhaus-Dahir, (2009) 
undertook epidemiological studies which indicated that the alterations of androgens and oestrogens 
implicated in disorders such as polycystic ovarian syndrome which is associated with obesity, insulin 
resistance, lipid disorders and ovulatory infertility also affects FSD (Eftekhar et al, 2014).  Hormonal 
imbalances accompanying diabetes such as thyroid and/or hypothalamic –pituitary disorders can further 
contribute (Bhasin et al, 2007). 
Psychological considerations 
FSD is generally a self-reported condition, thereby continues to be unrecognised and under reported 
(Thakar, 2009). FSD has an important impact on females’ quality of life. Filocamo et al, (2013) reported 
from their cross-sectional multi-centre study in gynaecological and urological clinics across Italy that under-
reporting of FSD reflected practitioners reluctance to ask females about their sexual life during 
consultations. Their study used the Female Sexual Function Index (FSFI) which is recognised as the gold 
standard for screening for FSD. 
Vafaeimanesh et al, (2014) in their descriptive analytical study recognised a strong association of women 
experiencing FSD with psychological health issues such as anxiety, depression, low self-esteem, body image 
perception disorders, sexual performance anxiety, fear of rejection, past traumatic sexual experience and 
history of abuse (Bancroft et al, 2003, Cyranowski et al, 2004).  Furthermore, Ismail et al, (2014) recognised 
that being diagnosed with diabetes or during a period of ill health might cause females to experience a loss 
of libido. Furthermore, obesity and being overweight are associated (independently of age) with FSD (Costa 
and Brody, 2014).  
Several factors have been associated with reduced or absent subjective sexual arousal and research has 
substantiated the association between sexual and mental health of women such as diminished desire and 
arousal (Kalmbach et al, 2014). Depression is twice as likely to be experienced by people living with 
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diabetes and one in three people with diabetes experience a significant loss in their quality of life due to 
depression, with the risk for females being higher than for males (Phillips, 2012). Several research studies 
have reported increased incidence of depression with lower educational levels (Kucuk et al, 2013, Lloyd et 
al, 2012, Yang et al, 2009, Stankunas et al, 2006, Sivrikaya et al, 2014). Practitioners also need to 
acknowledge the effects on sexual dysfunction of anti-depressant treatments. 
Associated to this, acknowledgement of the practical difficulties of living with diabetes can cause anxiety 
and distress which can further inhibit or trigger FSD.  Distress related to body image perception from 
worrying about the seemingly unsightly appearance of induced lipohypertrophy at injection sites can be 
inhibiting when engaged in sexual activity with new partners (Phillips & Khan, 2010). Additionally, for 
women who use insulin, fear of an unexpected hypoglycaemic episode during or after sex, or not 
recognising if a hypo is occurring can cause anxiety. 
Enzlin et al, (2009) as part of the EDIC Study Group reported females with diabetes had a more negative 
appraisal of their condition and more problems with their emotional adjustment to the disease. They also 
reported less satisfaction with their diabetes treatment. Enzlin et al (2009) also studied females who 
experienced diabetes related complications to those who were complication free at the time of their study. 
The difference between the two groups was significant as the females who were living with diabetes 
related complications including FSD blamed this ‘as another complication of the disease’.  Sarkadi and 
Rosenqvist (2003) identified in their cohort study of females with diabetes, the expression of guilt and 
embarrassment related to their diabetes, and Phillips (2014) identified diabetes related grief and distress 
as having a significant influence on women’s appraisal and perception of their diabetes. 
Additionally, problems relating to FSD are multi-factorial as recognised by Berman (2005). These can be 
connected to emotional and social difficulties in the woman’s life including work related, family or 
relationship distress. The quality of the relationship is recognised as a major factor, from research into 
women’s experiences of sexual dysfunction (Sivrikaya et al, 2014).  
What practitioners need to ask? 
Sexual health is very personal and women can feel embarrassed when asked about it. They might feel it 
more appropriate to see a female practitioner and they may or may not want to have their partner with 
them. Additionally, practitioners need to demonstrate cultural and / or religious sensitivities when 
discussing sexual health and wellbeing (Nelson, 2009). It is important for practitioners to be more aware of 
some of the causes and links between diabetes and FSD so women can be understood and helped 
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effectively. When reviewing women with sexual dysfunction a physical examination should be undertaken 
including the factors in table 1. 
Treatment options 
Women can be referred with their partners to a sexual relationship therapist with experience of working 
with couples to overcome sexual problems. The therapy aims to ease tensions and uses techniques such as 
Cognitive Behavioural Therapy and Sensate Focussing which helps couples to learn to touch each other in a 
sensual rather than sexual way in order to try to reduce possible tension and increase performance 
(Avagianou, 2015). These types of psychological approaches can be very helpful, however culturally 
sensitive approaches and awareness of religious preferences need acknowledgement when suggesting this 
type of therapy (Phillips & Khan, 2010). 
Psychological and physical problems have the potential to contribute to arousal disorders resulting in 
vaginal dryness. Advice regarding the use of over the counter water based lubricants can be the first step 
many women will benefit from.  
As highlighted, some FSD results from diminished blood flow to the clitoris, labia and vagina and 
stimulation with a mechanical vibrator may not achieve adequate engorgement because of poor blood 
flow. Treatment options do include a clitoral engorgement device which applies a gentle vacuum to 
engorge the clitoris even in the presence of diminished genital blood flow, this could have important 
treatment efficacy for women with diabetes (Billups, 2002). 
Some research is emerging regarding the efficaciousness of antioxidant therapies and the use of 
Phosphodiesterase type 5 inhibitors (Monte et al, 2014) however until more evidence is available, this 
remains experimental only. 
Conclusion 
Practitioners have a unique relationship with women with diabetes receiving care. Through acknowledging and 
recognising the increased risk of FSD and through effective consultation through partnership working in a person 
centred way this can be recognised and approached with sensitivity to help women who may feel embarrassed to 
broach this subject with practitioners believing it is their fault due to their diabetes. Reassuring consultation skills 
and having awareness of the evidence can enable effective consultations and treatment escalation as required to 
help women with their sexual health and sexuality. 
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Table 1 
 
Investigative guide to help asking women about sexual dysfunction in diabetes 
 
Diabetes Specific Questions Rationale 
What medications are you 
currently taking? 
To establish whether there are any possible iatrogenic-related influences that 
can be addressed. 
 
Are you experiencing any stress or  
depressive symptoms? 
To review if depression is present & to enable discussion if this is the case. 
Review of treatment if depression is already diagnosed. 
 
Have you recently had a baby? To find out whether the woman has experienced a difficult delivery or birth 
injuries, & whether she is getting enough sleep & has sufficient support to help 
her. 
 
Do you feel tired all the time? To establish whether this is due to hyper or hypoglycaemic unawareness, which 
can both cause fatigue. If the woman’s sleep pattern is disturbed, she may be 
experiencing anxiety, stress or depression. 
 
Do you experience vaginal 
dryness? 
To find out whether this is related to diabetes control, neuropathy, medication, 
hormones or the menopause & whether the woman would like to have 
treatment for this. 
 
Do you feel uncomfortable or 
experience  
pain during sex? 
 
To explore whether this maybe causing sexual anxiety. 
Do you experience recurrent 
infections, especially  
thrush or  urine infections? 
To investigate whether this is due to sub-optimal control of the woman’s 
diabetes. Fungal infections are easily treatable & advice regarding blood 
glucose control can be given. 
 
General Questions? Rationale 
Do you feel there is a problem 
with your relationship with your 
partner? 
 
To explore whether the woman is experiencing martial tensions or guilt about 
relationships, each of which can inhibit sexual experience. 
Do you feel embarrassed by 
having sex? 
To discover whether or not a past negative experience or previous abuse may 
be influencing the present situation. 
 
Do you feel you have a poor self-
image? 
To give the woman an opportunity to discuss any feelings of depression or low 
self-esteem, for example due to obesity, which can have a negative impact on 
sexual function. 
 
Have you ever experienced sexual 
or physical abuse? 
 
To discover whether the woman has a past negative experience (see above). 
Adapted from Phillips & Khan, 2010. 
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